Table 1.
Analytical sample characteristics, HRS 2016 VBS (N = 5959).
| Mean (SD) | Percent | Range | |
|---|---|---|---|
| Dementia Status | |||
| Normal | 83.1% | ||
| Cognitive Impairment without Dementia (CIND) | 13.6% | ||
| Dementia | 3.3% | ||
| Demographic Characteristics | |||
| Age | 68.7 (9.1) | 56–100 | |
| Female | 54.3% | ||
| Race/Ethnicity | |||
| Non-Hispanic Whites and Others | 82.0% | ||
| Non-Hispanic Black | 9.2% | ||
| Hispanic | 8.7% | ||
| Education (Years) | |||
| 0–12 | 43.4% | ||
| 13–15 | 25.5% | ||
| 16+ | 31.1% | ||
| APOE 4 | 0.3 (0.5) | 0–2 | |
| Inflammation | |||
| Albumin | 4.0 (0.3) | 2.2–5.5 | |
| CRP (log) | 0.8 (1.0) | −1.6-5.5 | |
| Neutrophil/Lymphocyte Ratio (NLR) | 2.3 (1.2) | 0.0–24.2 | |
| Num of High-Risk z scored Cytokine Quartiles | 1.3 (1.1) | 0–5 | |
| Immune Functioning Indicators | |||
| CMV Seronegative and Borderline | 37.0% | ||
| CMV Seropositive 1st Tertile (0.9–245.2 IgG Antibody) |
21.0% | ||
| CMV Seropositive 2nd Tertile (245.3–588.9 IgG Antibody) |
21.0% | ||
| CMV Seropositive 3rd Tertile (589.1–1817.0 IgG Antibody) |
21.0% | ||
| CD4+ TN/TM | 1.0 (0.7) | 0.00–7.1 | |
| CD8+ TN/TM | 0.4 (0.4) | 0.0–4.2 | |